Have a personal or library account? Click to login
Exploring adherence in patients with advanced breast cancer: focus on CDK4/6 inhibitors Cover

Exploring adherence in patients with advanced breast cancer: focus on CDK4/6 inhibitors

Open Access
|Dec 2023

Authors

Matea Baković

University of Zagreb, Faculty of Pharmacy and Biochemistry, Zagreb, Croatia

Martina Bago

Andrija Štampar Teaching Institute of Public Health, Zagreb, Croatia

Lucija Benić

University of Zagreb, Faculty of Pharmacy and Biochemistry, Zagreb, Croatia

Magdalena Krajinović

University of Zagreb, Faculty of Pharmacy and Biochemistry, Zagreb, Croatia

Tajana Silovski

University Hospital Centre, Department of Oncology, Zagreb, Croatia
University of Zagreb School of Medicine, Zagreb, Croatia

Natalija Dedić Plavetić

University Hospital Centre, Department of Oncology, Zagreb, Croatia
University of Zagreb School of Medicine, Zagreb, Croatia

Lu Turković

University of Zagreb, Faculty of Pharmacy and Biochemistry, Zagreb, Croatia

Miranda Sertić

University of Zagreb, Faculty of Pharmacy and Biochemistry, Zagreb, Croatia

Maja Ortner Hadžiabdić

mortner@pharma.unizg.hr

University of Zagreb, Faculty of Pharmacy and Biochemistry, Zagreb, Croatia
DOI: https://doi.org/10.2478/acph-2023-0045 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English
Page range: 633 - 654
Accepted on: Nov 30, 2023
Published on: Dec 26, 2023
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Related subjects:

© 2023 Matea Baković, Martina Bago, Lucija Benić, Magdalena Krajinović, Tajana Silovski, Natalija Dedić Plavetić, Lu Turković, Miranda Sertić, Maja Ortner Hadžiabdić, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.